Literature DB >> 31494111

Management of meibomian gland dysfunction: a review.

Saama Sabeti1, Ahmad Kheirkhah2, Jia Yin3, Reza Dana4.   

Abstract

Meibomian gland dysfunction is the leading cause of evaporative dry eye disease and is one of the most common conditions encountered by eye care providers. The disorder is characterized by obstruction of the meibomian gland terminal ducts and/or changes in their glandular secretion, resulting in changes in tear film stability, inflammation, and symptoms of irritation. There is no gold standard treatment for meibomian gland dysfunction, but rather a diversity of options. Conservative measures include warm compresses and lid hygiene, but there is growing interest and need for medical treatments and procedures. Potential medical treatments include antibiotics, nonsteroidal and steroidal anti-inflammatory agents, essential fatty acid supplementation, hormone therapy, and control of Demodex infestation. Procedures include intraductal meibomian gland probing, the use of electronic heating devices, intense pulsed light therapy, and intranasal neurostimulation. We provide an update on meibomian gland dysfunction treatments based on recent studies.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  blepharitis; dry eye disease; meibomian gland dysfunction; meibum; ocular surface disease

Mesh:

Year:  2019        PMID: 31494111     DOI: 10.1016/j.survophthal.2019.08.007

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  32 in total

Review 1.  A Review of Management Strategies for Nociceptive and Neuropathic Ocular Surface Pain.

Authors:  Harrison Dermer; Daniella Lent-Schochet; Despoina Theotoka; Christian Paba; Abdullah A Cheema; Ryan S Kim; Anat Galor
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 2.  Mouse models in studies on the etiology of evaporative dry eye disease.

Authors:  Made Airanthi K Widjaja-Adhi; Karina Chao; Marcin Golczak
Journal:  Exp Eye Res       Date:  2022-04-09       Impact factor: 3.770

3.  Evaluation of Meibomian Gland Dysfunction Among Ophthalmic Healthcare Workers.

Authors:  Alison Y Y Chan; Jasmine C Chuang; Victoria W Y Wong
Journal:  Clin Ophthalmol       Date:  2021-03-19

4.  Short-Term Effects of a Novel Eye Mask Producing Heat and Vibration for the Treatment of Meibomian Gland Dysfunction: A Pilot Study.

Authors:  Luca Vigo; Marco Pellegrini; Francesco Carones; Vincenzo Scorcia; Giuseppe Giannaccare
Journal:  J Ophthalmol       Date:  2021-08-17       Impact factor: 1.909

5.  Tea tree oil for Demodex blepharitis.

Authors:  Keyur Savla; Jimmy T Le; Andrew D Pucker
Journal:  Cochrane Database Syst Rev       Date:  2020-06-20

Review 6.  Alternative therapies for dry eye disease.

Authors:  Rhiya Mittal; Sneh Patel; Anat Galor
Journal:  Curr Opin Ophthalmol       Date:  2021-07-01       Impact factor: 4.299

Review 7.  Iatrogenic Dry Eye Disease: Dealing with the Conundrum of Post-Cataract Discomfort. A P.I.C.A.S.S.O. Board Narrative Review.

Authors:  Pasquale Aragona; Maurizio Rolando; Rita Mencucci; Roberto Vignapiano; Pierangela Rubino; Eleonora Favuzza; Emilia Cantera
Journal:  Ophthalmol Ther       Date:  2021-02-08

8.  Effects of lid debris debridement combined with meibomian gland expression on the ocular surface MMP-9 levels and clinical outcomes in moderate and severe meibomian gland dysfunction.

Authors:  Su Young Moon; Sol Ah Han; Hye Ji Kwon; So Young Park; Jae Hyuck Lee; Ho Seok Chung; Jae Yong Kim; Hungwon Tchah; Hun Lee
Journal:  BMC Ophthalmol       Date:  2021-04-12       Impact factor: 2.209

9.  Meibomian Gland Dysfunction: Intense Pulsed Light Therapy in Combination with Low-Level Light Therapy as Rescue Treatment.

Authors:  Leonidas Solomos; Walid Bouthour; Ariane Malclès; Gabriele Thumann; Horace Massa
Journal:  Medicina (Kaunas)       Date:  2021-06-14       Impact factor: 2.430

10.  A Survey on How Ocular Surface Demodex Infestation Interactively Associates with Diabetes Mellitus and Dry Eye Disease.

Authors:  Chang Huang; Shuze Chen; Sheng Fu; Yingli Li; Zhenhao Li; Siqi Li; Xiaoqian Liang; Zihong Wang; Zhoucheng Wang; Yifan Chen; Qixin Deng; Guoguo Yi; Min Fu
Journal:  Acta Parasitol       Date:  2021-04-03       Impact factor: 1.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.